Cindy Delbrook
Overview
Explore the profile of Cindy Delbrook including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
2943
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shalabi H, Sachdev V, Kulshreshtha A, Cohen J, Yates B, Rosing D, et al.
J Immunother Cancer
. 2020 Sep;
8(2).
PMID: 32883871
Background: Chimeric antigen receptor (CAR) T-cell-associated cytokine release syndrome (CRS) may present with tachycardia, hemodynamic instability and reduced cardiac function. Pediatric CAR studies examining cardiac toxicity are limited. Methods: We...
2.
Shah N, Highfill S, Shalabi H, Yates B, Jin J, Wolters P, et al.
J Clin Oncol
. 2020 Apr;
38(17):1938-1950.
PMID: 32286905
Purpose: Patients with B-cell acute lymphoblastic leukemia who experience relapse after or are resistant to CD19-targeted immunotherapies have limited treatment options. Targeting CD22, an alternative B-cell antigen, represents an alternate...
3.
Libert D, Yuan C, Masih K, Galera P, Salem D, Shalabi H, et al.
Leukemia
. 2020 Feb;
34(11):3064-3069.
PMID: 32103145
No abstract available.
4.
Shalabi H, Yuan C, Kulshreshtha A, Dulau-Florea A, Salem D, Gupta G, et al.
Pediatr Blood Cancer
. 2020 Jan;
67(4):e28149.
PMID: 31981407
Background: Accurate disease detection is integral to risk stratification in B-cell acute lymphoblastic leukemia (ALL). The gold standard used to evaluate response in the United States includes morphologic evaluation and...
5.
Cornetta K, Duffy L, Feldman S, Mackall C, Davila M, Curran K, et al.
Mol Ther Methods Clin Dev
. 2018 Sep;
10:371-378.
PMID: 30211249
Replication-competent retrovirus (RCR) is a safety concern for individuals treated with retroviral gene therapy. RCR detection assays are used to detect RCR in manufactured vector, transduced cell products infused into...
6.
Shalabi H, Wolters P, Martin S, Toledo-Tamula M, Roderick M, Struemph K, et al.
J Immunother
. 2018 Jul;
41(7):350-358.
PMID: 30048343
Neurotoxicity associated with CAR-T cell therapy can be life-threatening. With rapid development of CAR-T therapies, a systematic method is needed to identify and monitor symptoms of neurotoxicity, elucidate potential etiologies,...
7.
Shalabi H, Kraft I, Wang H, Yuan C, Yates B, Delbrook C, et al.
Haematologica
. 2018 Feb;
103(5):e215-e218.
PMID: 29419431
No abstract available.
8.
Fry T, Shah N, Orentas R, Stetler-Stevenson M, Yuan C, Ramakrishna S, et al.
Nat Med
. 2017 Nov;
24(1):20-28.
PMID: 29155426
Chimeric antigen receptor (CAR) T cells targeting CD19 mediate potent effects in relapsed and/or refractory pre-B cell acute lymphoblastic leukemia (B-ALL), but antigen loss is a frequent cause of resistance...
9.
Shah N, Loeb D, Khuu H, Stroncek D, Ariyo T, Raffeld M, et al.
Biol Blood Marrow Transplant
. 2016 Sep;
22(12):2149-2154.
PMID: 27634018
Relapse of hematologic malignancies is the primary cause of treatment failure after allogeneic hematopoietic stem cell transplantation (HCT). Treatment for post-HCT relapse using donor lymphocyte infusion (DLI) has limited utility,...
10.
Shah N, Merchant M, Cole D, Jayaprakash N, Bernstein D, Delbrook C, et al.
Pediatr Blood Cancer
. 2016 Feb;
63(6):997-1005.
PMID: 26891067
Background: Vincristine sulfate liposome injection (VSLI; Marqibo®) is an encapsulated preparation of standard vincristine in sphingomyelin/cholesterol liposomes. Clinical trials in adults have demonstrated safety, tolerability, and activity, leading to Food...